Literature DB >> 26258797

Frailty Phenotypes, Disability, and Outcomes in Adult Candidates for Lung Transplantation.

Jonathan P Singer1, Joshua M Diamond2, Cynthia J Gries3, Jamiela McDonnough4, Paul D Blanc1, Rupal Shah2, Monica Y Dean1, Beverly Hersh3, Paul J Wolters1, Sofya Tokman1, Selim M Arcasoy4, Kristy Ramphal2, John R Greenland1, Nancy Smith5, Pricilla Heffernan5, Lori Shah4, Pavan Shrestha1, Jeffrey A Golden1, Nancy P Blumenthal2, Debbie Huang1, Joshua Sonett4, Steven Hays1, Michelle Oyster2, Patricia P Katz1, Hilary Robbins4, Melanie Brown2, Lorriana E Leard1, Jasleen Kukreja6, Matthew Bacchetta5, Errol Bush6, Frank D'Ovidio5, Melanie Rushefski2, Kashif Raza4, Jason D Christie2,7, David J Lederer4,8.   

Abstract

RATIONALE: Frailty is associated with morbidity and mortality in abdominal organ transplantation but has not been examined in lung transplantation.
OBJECTIVES: To examine the construct and predictive validity of frailty phenotypes in lung transplant candidates.
METHODS: In a multicenter prospective cohort, we measured frailty with the Fried Frailty Phenotype (FFP) and Short Physical Performance Battery (SPPB). We evaluated construct validity through comparisons with conceptually related factors. In a nested case-control study of frail and nonfrail subjects, we measured serum IL-6, tumor necrosis factor receptor 1, insulin-like growth factor I, and leptin. We estimated the association between frailty and disability using the Lung Transplant Valued Life Activities disability scale. We estimated the association between frailty and risk of delisting or death before transplant using multivariate logistic and Cox models, respectively.
MEASUREMENTS AND MAIN RESULTS: Of 395 subjects, 354 completed FFP assessments and 262 completed SPPB assessments; 28% were frail by FFP (95% confidence interval [CI], 24-33%) and 10% based on the SPPB (95% CI, 7-14%). By either measure, frailty correlated more strongly with exercise capacity and grip strength than with lung function. Frail subjects tended to have higher plasma IL-6 and tumor necrosis factor receptor 1 and lower insulin-like growth factor I and leptin. Frailty by either measure was associated with greater disability. After adjusting for age, sex, diagnosis, and transplant center, both FFP and SPPB were associated with increased risk of delisting or death before lung transplant. For every 1-point worsening in score, hazard ratios were 1.30 (95% CI, 1.01-1.67) for FFP and 1.53 (95% CI, 1.19-1.59) for SPPB.
CONCLUSIONS: Frailty is prevalent among lung transplant candidates and is independently associated with greater disability and an increased risk of delisting or death.

Entities:  

Keywords:  biomarker; body composition; disability; frailty; lung transplantation

Mesh:

Substances:

Year:  2015        PMID: 26258797      PMCID: PMC4731703          DOI: 10.1164/rccm.201506-1150OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  64 in total

1.  Lower extremity performance in nondisabled older persons as a predictor of subsequent hospitalization.

Authors:  B W Penninx; L Ferrucci; S G Leveille; T Rantanen; M Pahor; J M Guralnik
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2000-11       Impact factor: 6.053

Review 2.  Cytokine-related aging process.

Authors:  John E Morley; Richard N Baumgartner
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2004-09       Impact factor: 6.053

3.  Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites.

Authors:  G Mantovani; A Macciò; L Mura; E Massa; M C Mudu; C Mulas; M R Lusso; C Madeddu; A Dessì
Journal:  J Mol Med (Berl)       Date:  2000       Impact factor: 4.599

4.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

5.  Hypoalbuminemia and early mortality after lung transplantation: a cohort study.

Authors:  M R Baldwin; S M Arcasoy; A Shah; P C Schulze; J Sze; J R Sonett; D J Lederer
Journal:  Am J Transplant       Date:  2012-02-15       Impact factor: 8.086

6.  Interleukin-6 and interferon-gamma gene polymorphisms in the development of bronchiolitis obliterans syndrome after lung transplantation.

Authors:  Kim C Lu; Andrés Jaramillo; Rachel L Lecha; Richard B Schuessler; Aviva Aloush; Elbert P Trulock; Eric N Mendeloff; Charles B Huddleston; G Alexander Patterson; T Mohanakumar
Journal:  Transplantation       Date:  2002-11-15       Impact factor: 4.939

7.  Frailty, core muscle size, and mortality in patients undergoing open abdominal aortic aneurysm repair.

Authors:  Jay Soong-Jin Lee; Kevin He; Calista M Harbaugh; Douglas E Schaubel; Christopher J Sonnenday; Stewart C Wang; Michael J Englesbe; Jonathan L Eliason
Journal:  J Vasc Surg       Date:  2011-01-07       Impact factor: 4.268

Review 8.  The pulmonary cachexia syndrome: aspects of energy balance.

Authors:  J Congleton
Journal:  Proc Nutr Soc       Date:  1999-05       Impact factor: 6.297

9.  Corticosteroids contribute to muscle weakness in chronic airflow obstruction.

Authors:  M Decramer; L M Lacquet; R Fagard; P Rogiers
Journal:  Am J Respir Crit Care Med       Date:  1994-07       Impact factor: 21.405

10.  Impact of cytokine expression in the pre-implanted donor lung on the development of chronic lung allograft dysfunction subtypes.

Authors:  T Saito; H Takahashi; H Kaneda; M Binnie; S Azad; M Sato; T K Waddell; M Cypel; M Liu; S Keshavjee
Journal:  Am J Transplant       Date:  2013-10-24       Impact factor: 8.086

View more
  60 in total

1.  Report from the American Society of Transplantation on frailty in solid organ transplantation.

Authors:  Jon Kobashigawa; Darshana Dadhania; Sangeeta Bhorade; Deborah Adey; Joseph Berger; Geetha Bhat; Marie Budev; Andres Duarte-Rojo; Michael Dunn; Shelley Hall; Meera N Harhay; Kirsten L Johansen; Susan Joseph; Cassie C Kennedy; Evan Kransdorf; Krista L Lentine; Raymond J Lynch; Mara McAdams-DeMarco; Shunji Nagai; Michael Olymbios; Jignesh Patel; Sean Pinney; Joanna Schaenman; Dorry L Segev; Palak Shah; Lianne G Singer; Jonathan P Singer; Christopher Sonnenday; Puneeta Tandon; Elliot Tapper; Stefan G Tullius; Michael Wilson; Martin Zamora; Jennifer C Lai
Journal:  Am J Transplant       Date:  2018-12-22       Impact factor: 8.086

Review 2.  Extracorporeal membrane oxygenation in the pre and post lung transplant period.

Authors:  Nirmal S Sharma; Mathew G Hartwig; Don Hayes
Journal:  Ann Transl Med       Date:  2017-02

3.  Clinician's Commentary on Schoo et al.1.

Authors:  Nancy Howes
Journal:  Physiother Can       Date:  2017       Impact factor: 1.037

4.  Editorial: Frailty, Comorbidity, and COPD.

Authors:  E Charbek; J R Espiritu; R Nayak; J E Morley
Journal:  J Nutr Health Aging       Date:  2018       Impact factor: 4.075

5.  Frailty and Clinical Outcomes in Chronic Obstructive Pulmonary Disease.

Authors:  Cassie C Kennedy; Paul J Novotny; Nathan K LeBrasseur; Robert A Wise; Frank C Sciurba; Roberto P Benzo
Journal:  Ann Am Thorac Soc       Date:  2019-02

Review 6.  Sarcopenia and frailty in chronic respiratory disease.

Authors:  Anna E Bone; Nilay Hepgul; Samantha Kon; Matthew Maddocks
Journal:  Chron Respir Dis       Date:  2017-02-24       Impact factor: 2.444

Review 7.  Frailty in the End-Stage Lung Disease or Heart Failure Patient: Implications for the Perioperative Transplant Clinician.

Authors:  Brandi A Bottiger; Alina Nicoara; Laurie D Snyder; Paul E Wischmeyer; Jacob N Schroder; Chetan B Patel; Mani A Daneshmand; Robert N Sladen; Kamrouz Ghadimi
Journal:  J Cardiothorac Vasc Anesth       Date:  2018-08-09       Impact factor: 2.628

8.  The sarcopenia index: A novel measure of muscle mass in lung transplant candidates.

Authors:  Kianoush Kashani; Kumar Sarvottam; Naveen L Pereira; Erin F Barreto; Cassie C Kennedy
Journal:  Clin Transplant       Date:  2018-01-17       Impact factor: 2.863

Review 9.  Frailty in Pulmonary and Critical Care Medicine.

Authors:  Jonathan P Singer; David J Lederer; Matthew R Baldwin
Journal:  Ann Am Thorac Soc       Date:  2016-08

10.  Significance of frailty for predicting adverse clinical outcomes in different patient groups with specific medical conditions.

Authors:  Martin Ritt; Karl-Günter Gaßmann; Cornel Christian Sieber
Journal:  Z Gerontol Geriatr       Date:  2016-09-14       Impact factor: 1.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.